A comprehensive view of AstraZeneca AB. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.
AstraZeneca AB Champions Sustainability and Respiratory Health Initiatives, Highlighting Decarbonization Goals and Public Health Collaboration
Published:
April 23, 2024
by Industry Intelligence Inc.
|
AstraZeneca AB Leads Industry in Environmental Sustainability and Public Health Initiatives, Targeting Carbon Neutrality by 2025 and Carbon Negativity by 2030
Published:
April 22, 2024
by Industry Intelligence Inc.
|
AstraZeneca Files United States Patent Application for Amino-Triazolopyridine Compounds and Their Use in Treating Cancer
Published:
April 22, 2024
by Pharmaceutical Patent News
|
INTERNATIONAL PATENT: ASTRAZENECA AB FILES APPLICATION FOR "PERFUSION BIOREACTOR TANGENTIAL FLOW FILTRATION"
Published:
April 22, 2024
by U.S. Fed News
|
AstraZeneca AB Champions Neurological Innovation and Gender Diversity in Leadership
Published:
April 20, 2024
by Industry Intelligence Inc.
|
Ask us about our Government & Public Policy market view